3
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37416 |
Tauro-α-muricholic Acid (sodium salt)
|
||
Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum. | |||
T63793 | Tauro-ω-muricholic acid sodium | ||
Tauro-ω-muricholic acid sodium (TωMCA sodium) 是一种tauro-α-muricholic acid 的类似物,是来源于肝脏的胆汁酸。Tauro-ω-muricholic acid sodium 能用作早发性新生儿败血症 (EOS) 和胆汁淤积的血清标志物。 | |||
T13093 |
Tauro-β-muricholic acid sodium
T-βMCA sodium |
FXR | Metabolism |
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19623 |
α-Muricholic acid
|
AChR | Neuroscience |
α-Muricholic acid is the most abundant primary bile acid in rodents. | |||
T40790 |
ω-Muricholic Acid
|
||
ω-Muricholic acid (ω-MCA) is a murine-specific secondary bile acid. | |||
T81030 |
Tauro-β-muricholic acid
TβMCA |
FXR | Metabolism |
Tauro-β-muricholic acid (TβMCA) 为一种具有三羟基结构的胆汁酸,是FXR的竞争性、可逆拮抗剂,IC50值为40 μM。此外,Tauro-β-muricholic acid 能够通过维持线粒体膜电位来阻抑胆汁酸引起的肝细胞凋亡,发挥抗凋亡功能。 | |||
T37997 |
Murideoxycholic Acid
|
||
Murideoxycholic acid (MDCA) is a secondary bile acid produced from α-muricholic acid and β-muricholic acid.[1] It is also a metabolite of lithocholic acid in liver S9 fractions from humans and other species.[2] MDCA prevents gallstone formation in hamsters fed a lithogenic diet but does not resolve gallstones in prairie dogs fed a high cholesterol diet.[3],[4] Gallstones formed during MDCA administration after a high cholesterol diet are comprised of an insoluble calcium salt of murideoxycholyl ... | |||
T35400 |
β-Muricholic Acid
β-MCA,5β-Cholanic Acid-3α,6β,7β-triol,β-Muricholic Acid |
||
β-Muricholic acid (β-MCA) is a murine-specific primary bile acid.[1],[2] Dietary administration of β-MCA reduces HMG-CoA reductase activity in liver microsomes from mice fed a high cholesterol and cholic acid diet.[3] Dietary administration of β-MCA also dissolves 100% of gallstones in a gallstone-susceptible mouse model of diet-induced cholesterol gallstones.[4] |